45 related articles for article (PubMed ID: 18855926)
1. Lesson of the month (1): cabergoline - 'i eat funny on that'.
Premaratne VS; Saeger I; Macdonald BK
Clin Med (Lond); 2014 Apr; 14(2):205-7. PubMed ID: 24715137
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of obsessive-compulsive disorder by intracellular acidification of cortical neurons with a proton pump inhibitor.
Hatakama H; Asaoka N; Nagayasu K; Shirakawa H; Kaneko S
Transl Psychiatry; 2024 Jan; 14(1):27. PubMed ID: 38228604
[TBL] [Abstract][Full Text] [Related]
3. Restless legs syndrome: Over 50 years of European contribution.
Khachatryan SG; Ferri R; Fulda S; Garcia-Borreguero D; Manconi M; Muntean ML; Stefani A
J Sleep Res; 2022 Aug; 31(4):e13632. PubMed ID: 35808955
[TBL] [Abstract][Full Text] [Related]
4. Increased Risk for New-Onset Psychiatric Adverse Events in Patients With Newly Diagnosed Primary Restless Legs Syndrome Who Initiate Treatment With Dopamine Agonists: A Large-Scale Retrospective Claims Matched-Cohort Analysis.
Hankin C; Lee D; Garcia-Borreguero D; Wang Z
J Clin Sleep Med; 2019 Sep; 15(9):1225-1232. PubMed ID: 31538593
[TBL] [Abstract][Full Text] [Related]
5. Brain Imaging and Impulse Control Disorders in Parkinson's Disease.
Roussakis AA; Lao-Kaim NP; Piccini P
Curr Neurol Neurosci Rep; 2019 Aug; 19(9):67. PubMed ID: 31396719
[TBL] [Abstract][Full Text] [Related]
6. Dopamine Agonists and Impulse Control Disorders: A Complex Association.
Grall-Bronnec M; Victorri-Vigneau C; Donnio Y; Leboucher J; Rousselet M; Thiabaud E; Zreika N; Derkinderen P; Challet-Bouju G
Drug Saf; 2018 Jan; 41(1):19-75. PubMed ID: 28861870
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of impulse control disorders in patients with movement disorders.
Mestre TA; Strafella AP; Thomsen T; Voon V; Miyasaki J
Ther Adv Neurol Disord; 2013 May; 6(3):175-88. PubMed ID: 23634190
[TBL] [Abstract][Full Text] [Related]
8. Sleep attacks in patients receiving dopamine-receptor agonists.
Plowman BK; Boggie DT; Morreale AP; Schaefer MG; Delattre ML; Chan H
Am J Health Syst Pharm; 2005 Mar; 62(5):537-40. PubMed ID: 15745920
[No Abstract] [Full Text] [Related]
9. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
Bayard S; Cochen De Cock V; Dauvillers Y
Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
[TBL] [Abstract][Full Text] [Related]
10. Punding in patients on dopamine agonists for restless leg syndrome.
Evans AH; Stegeman JR
Mov Disord; 2009 Jan; 24(1):140-1. PubMed ID: 18855926
[No Abstract] [Full Text] [Related]
11. [Impulse control disorder induced by the use of dopamine agonists].
Weber WE; Nijssen PC
Ned Tijdschr Geneeskd; 2009 Jan; 153(3):80-1. PubMed ID: 19235343
[No Abstract] [Full Text] [Related]
12. Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome.
Driver-Dunckley ED; Noble BN; Hentz JG; Evidente VG; Caviness JN; Parish J; Krahn L; Adler CH
Clin Neuropharmacol; 2007; 30(5):249-55. PubMed ID: 17909302
[TBL] [Abstract][Full Text] [Related]
13. Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling.
Kolla BP; Mansukhani MP; Barraza R; Bostwick JM
Psychosomatics; 2010; 51(3):271-3. PubMed ID: 20484726
[TBL] [Abstract][Full Text] [Related]
14. Dopamine agonist: pathological gambling and hypersexuality.
Prescrire Int; 2008 Oct; 17(97):200-1. PubMed ID: 19536937
[TBL] [Abstract][Full Text] [Related]
15. Pathological gambling associated with dopamine agonist use in restless legs syndrome.
Quickfall J; Suchowersky O
Parkinsonism Relat Disord; 2007 Dec; 13(8):535-6. PubMed ID: 17270485
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
